NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

白細胞介素抑制劑的全球市場 (2020-2030年) :COVID-19造成的成長與變化

Interleukin Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change

出版商 The Business Research Company 商品編碼 975751
出版日期 按訂單生產 內容資訊 英文 200 Pages
商品交期: 請詢問到貨日
價格
白細胞介素抑制劑的全球市場 (2020-2030年) :COVID-19造成的成長與變化 Interleukin Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change
出版日期: 按訂單生產內容資訊: 英文 200 Pages
簡介

本報告提供全球白細胞介素抑制劑市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地各國的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 白細胞介素抑制劑市場特徵

第3章 白細胞介素抑制劑的市場規模·成長率

  • 全球市場的實際成果 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素
  • 全球市場的預測 (以金額為準)
    • 市場促進因素
    • 市場阻礙因素

第4章 白細胞介素抑制劑市場區隔

  • 世界市場區隔:各類型,實際成果與預測 (以金額為準)
    • IL-17
    • IL-23
    • IL-1
    • IL-5
    • IL-6
    • 其他
  • 世界市場區隔:各應用領域,實際成果與預測 (以金額為準)
    • 乾癬
    • 乾癬性關節炎
    • 類風濕性關節炎
    • 氣喘
    • 發炎性腸道疾病
    • 其他
  • 世界市場區隔:實際成果與預測 (以金額為準)
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第5章 白細胞介素抑制劑市場:各地各國分析

  • 全球市場的區分:各地區,實際成果與預測 (以金額為準)
  • 全球市場的區分:各國,實際成果與預測 (以金額為準)

第6章 亞太地區的白細胞介素抑制劑市場

  • 市場概要
  • 市場區隔:各類型,實際成果與預測 (以金額為準)
  • 市場區隔:各應用領域,實際成果與預測 (以金額為準)

第7章 中國的白細胞介素抑制劑市場

第8章 印度的白細胞介素抑制劑市場

第9章 日本的白細胞介素抑制劑市場

第10章 澳洲的白細胞介素抑制劑市場

第11章 印尼的白細胞介素抑制劑市場

第12章 韓國的白細胞介素抑制劑市場

第13章 西歐的白細胞介素抑制劑市場

第14章 英國的白細胞介素抑制劑市場

第15章 德國的白細胞介素抑制劑市場

第16章 法國的白細胞介素抑制劑市場

第17章 東歐的白細胞介素抑制劑市場

第18章 俄羅斯的白細胞介素抑制劑市場

第19章 北美的白細胞介素抑制劑市場

第20章 美國的白細胞介素抑制劑市場

第21章 南美的白細胞介素抑制劑市場

第22章 巴西的白細胞介素抑制劑市場

第23章 中東的白細胞介素抑制劑市場

第24章 非洲的白細胞介素抑制劑市場

第25章 市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Sanofi
    • GlaxoSmithKline
    • Novartis
    • Johnson & Johnson
    • Roche

第26章 主要的收購與合併

第27章 市場趨勢與策略

第28章 未來展望和潛在性分析

第29章 附錄

目錄

“Interleukin Inhibitors Global Market Report 2020-30: Covid 19 Growth And Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global interleukin inhibitors global market report 2020-30 market.

This report focuses on interleukin inhibitors global market report 2020-30 market which is experiencing strong growth. The report gives a guide to the interleukin inhibitors global market report 2020-30 market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the interleukin inhibitors global market report 2020-30? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Interleukin Inhibitors Global Market Report 2020-30 ”market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider interleukin inhibitors global market report 2020-30 market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The interleukin inhibitors global market report 2020-30 market section of the report gives context. It compares the interleukin inhibitors global market report 2020-30 market with other segments of the interleukin inhibitors global market report 2020-30 market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, interleukin inhibitors global market report 2020-30 indicators comparison.

Scope

Markets Covered:

  • 1) By Type: IL-17; IL-23; IL-1; IL-5; IL-6; Others
  • 2) By Application: Psoriasis; Psoriatic Arthritis; Rheumatoid Arthritis; Asthma; Inflammatory Bowel Disease; Others
  • 3) By Aplication: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Sanofi; GlaxoSmithKline; Novartis; Johnson & Johnson; Roche
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Interleukin Inhibitors Market Characteristics

3. Interleukin Inhibitors Market Size And Growth

  • 3.1. Global Interleukin Inhibitors Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Interleukin Inhibitors Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Interleukin Inhibitors Market Segmentation

  • 4.1. Global Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • IL-17
  • IL-23
  • IL-1
  • IL-5
  • IL-6
  • Others
  • 4.2. Global Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Asthma
  • Inflammatory Bowel Disease
  • Others
  • 4.3. Global Interleukin Inhibitors Market, Segmentation By Aplication, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

5. Interleukin Inhibitors Market Regional And Country Analysis

  • 5.1. Global Interleukin Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Interleukin Inhibitors Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Interleukin Inhibitors Market

  • 6.1. Asia-Pacific Interleukin Inhibitors Market Overview
  • 6.2. Asia-Pacific Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Interleukin Inhibitors Market

  • 7.1. China Interleukin Inhibitors Market Overview
  • 7.2. China Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Interleukin Inhibitors Market

  • 8.1. India Interleukin Inhibitors Market Overview
  • 8.2. India Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Interleukin Inhibitors Market

  • 9.1. Japan Interleukin Inhibitors Market Overview
  • 9.2. Japan Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Interleukin Inhibitors Market

  • 10.1. Australia Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Interleukin Inhibitors Market

  • 11.1. Indonesia Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Interleukin Inhibitors Market

  • 12.1. South Korea Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Interleukin Inhibitors Market

  • 13.1. Western Europe Interleukin Inhibitors Market Overview
  • 13.2. Western Europe Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Interleukin Inhibitors Market

  • 14.1. UK Interleukin Inhibitors Market Overview
  • 14.2. UK Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Interleukin Inhibitors Market

  • 15.1. Germany Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Interleukin Inhibitors Market

  • 16.4. France Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Interleukin Inhibitors Market

  • 17.1. Eastern Europe Interleukin Inhibitors Market Overview
  • 17.2. Eastern Europe Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Interleukin Inhibitors Market

  • 18.1. Russia Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Interleukin Inhibitors Market

  • 19.1. North America Interleukin Inhibitors Market Overview
  • 19.2. North America Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Interleukin Inhibitors Market

  • 20.1. USA Interleukin Inhibitors Market Overview
  • 20.2. USA Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Interleukin Inhibitors Market

  • 21.1. South America Interleukin Inhibitors Market Overview
  • 21.2. South America Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Interleukin Inhibitors Market

  • 22.1. Brazil Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Interleukin Inhibitors Market

  • 23.1. Middle East Interleukin Inhibitors Market Overview
  • 23.2. Middle East Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Interleukin Inhibitors Market

  • 24.1. Africa Interleukin Inhibitors Market Overview
  • 24.2. Africa Interleukin Inhibitors Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Interleukin Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Interleukin Inhibitors Market Competitive Landscape And Company Profiles

  • 25.1. Interleukin Inhibitors Market Competitive Landscape
  • 25.2. Interleukin Inhibitors Market Company Profiles
    • 25.2.1. Sanofi
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. GlaxoSmithKline
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Johnson & Johnson
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Roche
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Interleukin Inhibitors Market

27. Interleukin Inhibitors Market Trends And Strategies

28. Interleukin Inhibitors Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer